{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T04:14:35Z","timestamp":1789877675683,"version":"4.0.1"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,23]]},"DOI":"10.7759\/cureus.95252","type":"journal-article","created":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T21:21:58Z","timestamp":1761254518000},"source":"Crossref","is-referenced-by-count":1,"title":["Microshunt Matchup: XEN vs. PRESERFLO in the Arena of Primary Open-Angle Glaucoma"],"prefix":"10.7759","author":[{"given":"Mohammad","family":"Ayoub","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Alnahrawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.11686","article-title":"Epidemiology of glaucoma: the past, present, and predictions for the future","volume":"12","author":"Allison K","year":"2020","unstructured":"Allison K, Patel D, Alabi O. Epidemiology of glaucoma: the past, present, and predictions for the future. Cureus. 2020, 12:e11686. 10.7759\/cureus.11686","journal-title":"Cureus"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3238\/arztebl.2020.0225","article-title":"The diagnosis and treatment of glaucoma","volume":"117","author":"Schuster AK","year":"2020","unstructured":"Schuster AK, Erb C, Hoffmann EM, Dietlein T, Pfeiffer N. The diagnosis and treatment of glaucoma. Dtsch Arztebl Int. 2020, 117:225-234. 10.3238\/arztebl.2020.0225","journal-title":"Dtsch Arztebl Int"},{"key":"ref3","article-title":"Glaucoma","volume":"93","author":"Gupta D","year":"2016","unstructured":"Gupta D, Chen PP. Glaucoma. Am Fam Physician. 2016, 93:668-674.","journal-title":"Am Fam Physician"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2020.06.051","article-title":"Trends in glaucoma surgeries performed by glaucoma subspecialists versus nonsubspecialists on Medicare beneficiaries from 2008 through 2016","volume":"128","author":"Rathi S","year":"2021","unstructured":"Rathi S, Andrews CA, Greenfield DS, Stein JD. Trends in glaucoma surgeries performed by glaucoma subspecialists versus nonsubspecialists on Medicare beneficiaries from 2008 through 2016. Ophthalmology. 2021, 128:30-38. 10.1016\/j.ophtha.2020.06.051","journal-title":"Ophthalmology"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ogla.2022.08.007","article-title":"Burden of glaucoma in the United Kingdom: a multicenter analysis of United Kingdom glaucoma services","volume":"6","author":"Fu DJ","year":"2023","unstructured":"Fu DJ, Ademisoye E, Shih V, McNaught AI, Khawaja AP. Burden of glaucoma in the United Kingdom: a multicenter analysis of United Kingdom glaucoma services. Ophthalmol Glaucoma. 2023, 6:106-115. 10.1016\/j.ogla.2022.08.007","journal-title":"Ophthalmol Glaucoma"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1186\/s40662-019-0162-1","article-title":"Ab externo implantation of the MicroShunt, a poly (styrene-block-isobutylene-block-styrene) surgical device for the treatment of primary open-angle glaucoma: a review","volume":"6","author":"Sadruddin O","year":"2019","unstructured":"Sadruddin O, Pinchuk L, Angeles R, Palmberg P. Ab externo implantation of the MicroShunt, a poly (styrene-block-isobutylene-block-styrene) surgical device for the treatment of primary open-angle glaucoma: a review. Eye Vis (Lond). 2019, 6:36. 10.1186\/s40662-019-0162-1","journal-title":"Eye Vis (Lond)"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph20042904","article-title":"The PreserFlo MicroShunt in the the context of minimally invasive glaucoma surgery: a narrative review","volume":"20","author":"Saeed E","year":"2023","unstructured":"Saeed E, Go\u0142aszewska K, Dmuchowska DA, Zalewska R, Konopi\u0144ska J. The PreserFlo MicroShunt in the the context of minimally invasive glaucoma surgery: a narrative review\r\n. Int J Environ Res Public Health. 2023, 20:2904. 10.3390\/ijerph20042904","journal-title":"Int J Environ Res Public Health"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S178348","article-title":"XEN(\u00ae) Gel Stent: a comprehensive review on its use as a treatment option for refractory glaucoma","volume":"14","author":"Fea AM","year":"2020","unstructured":"Fea AM, Durr GM, Marolo P, Malinverni L, Economou MA, Ahmed I. XEN(\u00ae) Gel Stent: a comprehensive review on its use as a treatment option for refractory glaucoma. Clin Ophthalmol. 2020, 14:1805-1832. 10.2147\/OPTH.S178348","journal-title":"Clin Ophthalmol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/aos.14602","article-title":"XEN(\u00ae) Gel Stent compared to PRESERFLO\u2122 MicroShunt implantation for primary open-angle glaucoma: two-year results","volume":"99","author":"Scheres LM","year":"2021","unstructured":"Scheres LM, Kujovic-Aleksov S, Ramdas WD, et al.. XEN(\u00ae) Gel Stent compared to PRESERFLO\u2122 MicroShunt implantation for primary open-angle glaucoma: two-year results. Acta Ophthalmol. 2021, 99:e433-e440. 10.1111\/aos.14602","journal-title":"Acta Ophthalmol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2021.05.023","article-title":"Ab-externo MicroShunt versus trabeculectomy in primary open-angle glaucoma: one-year results from a two-year randomized, multicenter study","volume":"128","author":"Baker ND","year":"2021","unstructured":"Baker ND, Barnebey HS, Moster MR, et al.. Ab-externo MicroShunt versus trabeculectomy in primary open-angle glaucoma: one-year results from a two-year randomized, multicenter study. Ophthalmology. 2021, 128:1710-1721. 10.1016\/j.ophtha.2021.05.023","journal-title":"Ophthalmology"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-023-06075-4","article-title":"PRESERFLO \u2122 MicroShunt versus trabeculectomy: 1-year results on efficacy and safety","volume":"261","author":"Jamke M","year":"2023","unstructured":"Jamke M, Herber R, Haase MA, Jasper CS, Pillunat LE, Pillunat KR. PRESERFLO \u2122 MicroShunt versus trabeculectomy: 1-year results on efficacy and safety. Graefes Arch Clin Exp Ophthalmol. 2023, 261:2901-2915. 10.1007\/s00417-023-06075-4","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ogla.2021.07.008","article-title":"Safety and effectiveness of the PRESERFLO MicroShunt in primary open-angle glaucoma: results from a two-year multicenter study","volume":"5","author":"Beckers HJ","year":"2022","unstructured":"Beckers HJ, Aptel F, Webers CA, et al.. Safety and effectiveness of the PRESERFLO MicroShunt in primary open-angle glaucoma: results from a two-year multicenter study. Ophthalmol Glaucoma. 2022, 5:195-209. 10.1016\/j.ogla.2021.07.008","journal-title":"Ophthalmol Glaucoma"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1038\/s41433-022-01995-7","article-title":"Short-term safety and efficacy of Preserflo\u2122 Microshunt in glaucoma patients: a multicentre retrospective cohort study","volume":"37","author":"Bhayani R","year":"2023","unstructured":"Bhayani R, Mart\u00ednez de la Casa JM, Figus M, Klabe K, Rabiolo A, Mercieca K. Short-term safety and efficacy of Preserflo\u2122 Microshunt in glaucoma patients: a multicentre retrospective cohort study. Eye (Lond). 2023, 37:644-649. 10.1038\/s41433-022-01995-7","journal-title":"Eye (Lond)"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-021-01811-w","article-title":"Efficacy and safety of PreserFlo MicroShunt after a failed trabeculectomy in eyes with primary open-angle glaucoma: a retrospective study","volume":"38","author":"Quaranta L","year":"2021","unstructured":"Quaranta L, Micheletti E, Carassa R, Bruttini C, Fausto R, Katsanos A, Riva I. Efficacy and safety of PreserFlo MicroShunt after a failed trabeculectomy in eyes with primary open-angle glaucoma: a retrospective study. Adv Ther. 2021, 38:4403-4412. 10.1007\/s12325-021-01811-w","journal-title":"Adv Ther"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-019-04251-z","article-title":"Two-year results of a multicenter study of the ab interno gelatin implant in medically uncontrolled primary open-angle glaucoma","volume":"257","author":"Reitsamer H","year":"2019","unstructured":"Reitsamer H, Sng C, Vera V, Lenzhofer M, Barton K, Stalmans I. Two-year results of a multicenter study of the ab interno gelatin implant in medically uncontrolled primary open-angle glaucoma. Graefes Arch Clin Exp Ophthalmol. 2019, 257:983-996. 10.1007\/s00417-019-04251-z","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1097\/IJG.0000000000002302","article-title":"XEN 45 Gel Stent implantation in open-angle glaucoma: five-year results of a prospective study","volume":"32","author":"Torbey J","year":"2023","unstructured":"Torbey J, Paillard A, Rao HL, Gillman K, Bravetti GE, Mermoud A, Mansouri K. XEN 45 Gel Stent implantation in open-angle glaucoma: five-year results of a prospective study. J Glaucoma. 2023, 32:909-917. 10.1097\/IJG.0000000000002302","journal-title":"J Glaucoma"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-76551-y","article-title":"Comparing the efficacy of trabeculectomy and XEN gel microstent implantation for the treatment of primary open-angle glaucoma: a retrospective monocentric comparative cohort study","volume":"10","author":"Theilig T","year":"2020","unstructured":"Theilig T, Rehak M, Busch C, Bormann C, Schargus M, Unterlauft JD. Comparing the efficacy of trabeculectomy and XEN gel microstent implantation for the treatment of primary open-angle glaucoma: a retrospective monocentric comparative cohort study. Sci Rep. 2020, 10:19337. 10.1038\/s41598-020-76551-y","journal-title":"Sci Rep"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-61319-1","article-title":"Efficacy and safety at 6 months of the XEN implant for the management of open angle glaucoma","volume":"10","author":"Buffault J","year":"2020","unstructured":"Buffault J, Graber M, Bensmail D, et al.. Efficacy and safety at 6 months of the XEN implant for the management of open angle glaucoma. Sci Rep. 2020, 10:4527. 10.1038\/s41598-020-61319-1","journal-title":"Sci Rep"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1038\/s41433-024-03042-z","article-title":"Three-year clinical outcome of XEN45 Gel Stent implantation versus trabeculectomy in patients with open angle glaucoma","volume":"38","author":"Rauchegger T","year":"2024","unstructured":"Rauchegger T, Krause SM, Nowosielski Y, Huber AL, Willeit P, Schmid E, Teuchner B. Three-year clinical outcome of XEN45 Gel Stent implantation versus trabeculectomy in patients with open angle glaucoma. Eye (Lond). 2024, 38:1908-1916. 10.1038\/s41433-024-03042-z","journal-title":"Eye (Lond)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/418535-microshunt-matchup-xen-vs-preserflo-in-the-arena-of-primary-open-angle-glaucoma","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T21:21:58Z","timestamp":1761254518000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/418535-microshunt-matchup-xen-vs-preserflo-in-the-arena-of-primary-open-angle-glaucoma"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,23]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.95252","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10,23]]}}}